Clinical Trial

Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition.

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated December 5, 2025 (before its estimated January 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the safety and pharmacokinetic characteristics of DWJ1622, DWC202313, and DWC202314 in healthy adult volunteers under fed conditions.
Trial Details
NCT Number NCT07267221
Lead Sponsor Daewoong Pharmaceutical Co. LTD.
Conditions Healthy Volunteers
Enrollment 36 participants
Start Date 2025-12-01
Primary Completion 2026-01-30 (estimated)
Study Completion 2026-05-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-05